What does CUSIP 604749101 represent in this 13F holders report?

CUSIP 604749101 is the security identifier for MIRM - Mirum Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in Q1 2020?

43 institutional investors reported MIRM - Mirum Pharmaceuticals, Inc. - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)

CUSIP: 604749101

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock
Shares outstanding: 60,799,281
Total 13F shares: 18,603,225
Share change: +2,354,315
Total reported value: $260,445,000
Price per share: $14.00
Number of holders: 43
Value change: +$32,083,278
Number of buys: 30
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 604749101?
CUSIP 604749101 identifies MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 604749101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
NEA Management Company, LLC	13F	Company	6.9%	4,187,801	$102,685,000	—	31 Dec 2019	13F
FRAZIER MANAGEMENT LLC	13F	Company	5.9%	3,566,912	$87,461,000	—	31 Dec 2019	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	5.7%	3,448,912	$84,567,000	—	31 Dec 2019	13F
Novo Holdings A/S	13F	Company	4%	2,445,147	$59,955,000	—	31 Dec 2019	13F
Rock Springs Capital Management LP	13F	Company	2%	1,245,000	$30,527,000	—	31 Dec 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	0.55%	333,333	$8,173,000	—	31 Dec 2019	13F
Boxer Capital, LLC	13F	Company	0.52%	317,000	$7,773,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	0.3%	181,169	$4,442,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	0.13%	80,433	$1,972,000	—	31 Dec 2019	13F
ORBIMED ADVISORS LLC	13F	Company	0.12%	71,300	$1,748,000	—	31 Dec 2019	13F
Global IMC LLC	13F	Company	0.1%	60,509	$1,484,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.1%	58,568	$1,436,000	—	31 Dec 2019	13F
Informed Momentum Co LLC	13F	Company	0.08%	46,786	$1,147,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.08%	46,612	$1,142,000	—	31 Dec 2019	13F
Worth Venture Partners, LLC	13F	Company	0.04%	27,148	$666,000	—	31 Dec 2019	13F
Alyeska Investment Group, L.P.	13F	Company	0.04%	27,080	$664,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0.04%	22,819	$560,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	22,271	$546,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.02%	11,508	$282,000	—	31 Dec 2019	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.01%	8,843	$217,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.01%	6,232	$152,000	—	31 Dec 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	5,385	$132,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	0.01%	4,817	$118,000	—	31 Dec 2019	13F
Ensign Peak Advisors, Inc	13F	Company	0.01%	4,706	$116,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	4,276	$105,000	—	31 Dec 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	4,086	$100,000	—	31 Dec 2019	13F
Lindbrook Capital, LLC	13F	Company	0%	2,000	$49,000	—	31 Dec 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	1,684	$41,000	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0%	1,612	$40,000	—	31 Dec 2019	13F
Marshall Wace North America L.P.	13F	Company	0%	1,011	$25,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0%	897	$21,000	—	31 Dec 2019	13F
STRS OHIO	13F	Company	0%	700	$17,000	—	31 Dec 2019	13F
Legal & General Group Plc	13F	Company	0%	551	$14,000	—	31 Dec 2019	13F
CITIGROUP INC	13F	Company	0%	540	$13,000	—	31 Dec 2019	13F
Parallel Advisors, LLC	13F	Company	0%	400	$10,000	—	31 Dec 2019	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	339	$8,000	—	31 Dec 2019	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	225	$6,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	219	$5,000	—	31 Dec 2019	13F
ROYAL BANK OF CANADA	13F	Company	0%	79	$2,000	—	31 Dec 2019	13F

Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q1 2020

As of 31 Mar 2020, Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,603,225 shares. The largest 10 holders included NEA Management Company, LLC, FRAZIER MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Novo Holdings A/S, Rock Springs Capital Management LP, Polar Capital LLP, BAKER BROS. ADVISORS LP, Sofinnova Investments, Inc., BOXER CAPITAL, LLC, and BlackRock Inc.. This page lists 43 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

Q1 2020 holders

Holder diff

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.